Concepedia

Ludovica Monti

LM

Statistics

Publications

14

Citations

425

H-Index

12

Active since

2015

Affiliations

University of California San Diego(Current)

University of Montana

Sapienza University of Rome

Center for Discovery

University of Pennsylvania

Ludovica Monti is an author at University of California San Diego specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2015–2023

14

Publications

14

New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer

Giuseppe La Regina, Ruoli Bai, Antonio Coluccia et al. · Journal of Medicinal Chemistry · 2015 · 58 citations · Full text

, , +17

Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional Group

Pierrik Lassalas, Killian Oukoloff, Vishruti Makani et al. · ACS Medicinal Chemistry Letters · 2017 · 54 citations · Full text

, , +17

Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases

Anne‐Sophie Cornec, Ludovica Monti, Jane Kovalevich et al. · Journal of Medicinal Chemistry · 2017 · 50 citations · Full text

, , +17

Discovery of 1,1′-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors

Giuseppe La Regina, Antonio Coluccia, Valeria Famiglini et al. · Journal of Medicinal Chemistry · 2015 · 45 citations · Full text

, , +16

Structure-Based Optimization of Quinazolines as Cruzain and <i>Tbr</i>CATL Inhibitors

Elany Barbosa da Silva, Débora Assumpção Rocha, Isadora Serraglio Fortes et al. · Journal of Medicinal Chemistry · 2021 · 38 citations · Full text

, , +16

1–5 of 14